Shares of ALK-Abelló A/S (OTC:AKBLF – Get Free Report) were up 1.4% during trading on Monday . The company traded as high as $20.59 and last traded at $20.59. Approximately 5 shares were traded during trading, a decline of 98% from the average daily volume of 300 shares. The stock had previously closed at $20.30.
ALK-Abelló A/S Price Performance
The stock’s 50-day moving average price is $20.92 and its two-hundred day moving average price is $22.70.
ALK-Abelló A/S Company Profile
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food.
Read More
- Five stocks we like better than ALK-Abelló A/S
- How to Evaluate a Stock Before Buying
- Energy Transfer: Powering Data With Dividends and Diversification
- Breakout Stocks: What They Are and How to Identify Them
- Qualcomm Stock Is Coiling for a Breakout
- What Investors Need to Know About Upcoming IPOs
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
